BCG vaccination is associated with decreased severity of tuberculosis in Pakistan

Zahra Hasan1, Muhammad Irfan1, Javaid A Khan1

  • 1The Aga Khan University, Karachi, Pakistan.

Insights

Bacille Calmette-Guérin (BCG) vaccination may protect against severe tuberculosis (TB) forms in Pakistan. Higher BCG vaccination rates were observed in tuberculous lymphadenitis cases, suggesting localized protection in this high-burden region.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Public Health

Background:

  • Pakistan is a high-burden tuberculosis (TB) country, with BCG vaccination administered at birth.
  • TB incidence in Pakistan is 231/100,000 population.
  • Understanding BCG's effectiveness against different TB forms is crucial for public health strategies.

Purpose of the Study:

  • To investigate the association between BCG vaccination status and the severity of tuberculosis in Pakistan.
  • To determine if BCG vaccination influences the type of TB infection (pulmonary vs. extrapulmonary) or specific forms like tuberculous lymphadenitis.

Main Methods:

  • A cross-sectional, multi-center, hospital-based study.
  • Recruited 218 TB patients (pulmonary and extrapulmonary).
  • Documented BCG vaccination scar presence and classified TB severity.

Main Results:

  • No significant difference in BCG vaccination status was found between pulmonary TB (PTB) and extrapulmonary TB (ETB) cases, or by age and gender.
  • A significantly greater number of tuberculous lymphadenitis (LNTB) cases had received BCG vaccinations compared to pleural TB and tuberculous meningitis.
  • More vaccinated patients had pulmonary TB than pleural TB.

Conclusions:

  • BCG vaccination may offer protection against more severe forms of TB, particularly localized tuberculous lymphadenitis.
  • Findings suggest BCG's protective role in specific TB manifestations within a high-burden setting.
  • Further research is warranted to elucidate BCG's mechanism of protection against diverse TB presentations.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
768
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
632
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Vaccinations01:51

Vaccinations

Overview
53.6K